2010: Dissecting the Biology and Genetics of c-Kit Mutations in Canine Mast Cell Tumors
Grant Status: Closed
The most common malignant tumor in dogs is the mast cell tumor (MCT, a form of skin cancer), occurring with an incidence of close to 20 percent in the canine population. Particular breeds of dog are at risk for the development of this tumor, indicating a role for genetic factors. MCTs range from relatively benign to extremely aggressive, leading to tumor spread and eventual death. Although surgical removal with or without radiation therapy may cure some patients, there are no effective treatments for dogs with aggressive MCTs. We have previously identified mutations in the gene c-kit in several dog MCTs. c-Kit plays a critical role in regulating the growth and function of normal mast cells, and as the mutations we discovered cause uncontrolled function of c-kit, it is likely they influence MCT development in dogs. This research will explore the unique characteristics of the canine genome that lead to such a high frequency of c-kit mutations, as well as investigate the biological effects of such mutations on mast cells. In summary, this work will provide a much more detailed understanding of dog MCTs, thereby building a framework for the development of new therapies and strategies for disease prevention.
Downing, S., Chien, M. B., Kass, P. H., Moore, P. F., & London, C. A. (2002). Prevalence and importance of internal tandem duplications in exons 11 and 12 of c- kit in mast cell tumors of dogs. American Journal of Veterinary Research, 63(12), 1718–1723. https://doi.org/10.2460/ajvr.2002.63.1718
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.